Cargando…
Testing Beneficial Therapy in Human Cirrhosis Using Animal Models of Cirrhosis
Autores principales: | Hoefs, John Carl, Morgan, Timothy, Ilagan, Bernard Joseph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059786/ https://www.ncbi.nlm.nih.gov/pubmed/21365242 http://dx.doi.org/10.1007/s10620-011-1578-1 |
Ejemplares similares
-
309 Quantitative tests (QLFTS) detect impaired hepatic function in a high proportion of chronic hepatitis C patients with fibrosis or compensated cirrhosis and may predict risk of cirrhosis, splenomegally, and varices
por: Everson, Gregory T., et al.
Publicado: (2003) -
Testing for cirrhosis
por: Gupta, Sidhartha, et al.
Publicado: (2021) -
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
por: Tonon, Marta, et al.
Publicado: (2021) -
Hepatic Cirrhosis in Children
Publicado: (1888) -
Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)